Enhanced trabecular-bone calcium deposition in female rats with a high physiological dose of prolactin diminishes after ovariectomy
- PMID: 17218965
- DOI: 10.1139/y06-047
Enhanced trabecular-bone calcium deposition in female rats with a high physiological dose of prolactin diminishes after ovariectomy
Abstract
Although an increase in trabecular-bone calcium deposition has been shown to be regulated by prolactin during lactation, the physiological significance of prolactin in bone calcium metabolism in nonlactating rats remains unclear. This investigation sought to demonstrate the effects of endogenous prolactin and a high physiological dose of exogenous prolactin on bone turnover and bone calcium deposition in normal female rats, using the 45Ca-labeling technique. Our results showed that suppression of endogenous prolactin with 6 mg/kg bromocriptine for 15 days significantly enhanced bone formation, but not bone resorption, in primarily trabecular sites, resulting in a significant increase in calcium deposition in the sternum and vertebrae, from -0.20+/-0.07 to 0.40+/-0.09 (p<0.05) and -0.07+/-0.11 to 0.34+/-0.06 (p<0.05) mmol Ca.(g dry mass)-1, respectively. Similarly, 2.5 mg/kg prolactin, a high physiological dose, increased sternal and vertebral calcium deposition, from -0.20+/-0.07 to 0.24+/-0.09 (p<0.05) and -0.07+/-0.11 to 0.25+/-0.18 (p<0.05) mmol Ca.(g dry mass)-1, respectively, by increasing bone formation more than bone resorption. However, as expected, prolactin had no effect on the tibia or femur, which are primarily cortical sites. Because several actions of prolactin have been known to be estradiol-dependent, we further investigated the dependence of prolactin action on 17beta-estradiol. We found that 2.5 mg/kg prolactin did not increase sternal calcium deposition in ovariectomized rats. However, 10 microg/kg 17beta-estradiol supplementation restored the action of prolactin. Ovariectomized rats given 17beta-estradiol plus prolactin also manifested slightly but significantly higher sternal total calcium content than sham-operated rats, (4.58+/-0.12 vs. 4.36+/-0.11 mmol Ca.(g dry mass)-1 (p<0.05)). We concluded that a high physiological dose of prolactin promoted calcium deposition in primarily trabecular sites of nonlactating rats. This effect was diminished after ovariectomy. In addition, we showed that basal endogenous prolactin played a role in the maintenance of normal trabecular-bone turnover.
Similar articles
-
High-calcium diet modulates effects of long-term prolactin exposure on the cortical bone calcium content in ovariectomized rats.Am J Physiol Endocrinol Metab. 2007 Feb;292(2):E443-52. doi: 10.1152/ajpendo.00333.2006. Epub 2006 Sep 26. Am J Physiol Endocrinol Metab. 2007. PMID: 17003239
-
Effects of acute and long-term administration of prolactin on bone 45Ca uptake, calcium deposit, and calcium resorption in weaned, young, and mature rats.Can J Physiol Pharmacol. 1996 Oct;74(10):1157-65. Can J Physiol Pharmacol. 1996. PMID: 9022836
-
The study of a physiological significance of prolactin in the regulation of calcium metabolism during pregnancy and lactation in rats.Can J Physiol Pharmacol. 1998 Feb;76(2):218-28. Can J Physiol Pharmacol. 1998. PMID: 9635163
-
The in vivo anabolic actions of prostaglandins in bone.Bone. 1997 Oct;21(4):297-304. doi: 10.1016/s8756-3282(97)00147-6. Bone. 1997. PMID: 9315332 Review. No abstract available.
-
Calcium turnover and nutrition through the life cycle.Proc Nutr Soc. 2001 May;60(2):283-9. doi: 10.1079/pns200082. Proc Nutr Soc. 2001. PMID: 11681644 Review.
Cited by
-
Osteoporosis associated with antipsychotic treatment in schizophrenia.Int J Endocrinol. 2013;2013:167138. doi: 10.1155/2013/167138. Epub 2013 Apr 17. Int J Endocrinol. 2013. PMID: 23690768 Free PMC article.
-
Femoral bone mineral density and bone mineral content in bromocriptine-treated pregnant and lactating rats.J Physiol Sci. 2010 Jan;60(1):1-8. doi: 10.1007/s12576-009-0059-1. Epub 2009 Sep 17. J Physiol Sci. 2010. PMID: 19760135 Free PMC article.
-
Paeoniflorin Ameliorates Hyperprolactinemia-Induced Inhibition of Osteoblastogenesis by Suppressing the NF-κB Signaling Pathway.Int J Endocrinol. 2022 Apr 15;2022:4572033. doi: 10.1155/2022/4572033. eCollection 2022. Int J Endocrinol. 2022. PMID: 35465073 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases